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Dear Editor-in-Chief 
 
Global Breast Cancer (BC) is the most common 
non-skin malignancy, nearly a third of newly di-
agnosed cancers in the United States and the 
second leading cause of mortality in women 
throughout the world  was BC (1, 2). Between 
1975 and 2000 the burden of BC has doubled, 
that is attributable to the increase in life expec-
tancy and spread of unhealthy lifestyle (3). Never-
theless, these trends are not visible in early onset 
of BC, as the rates have been more or less stable 
in most countries in the past 20 yr (4). As for 
mortality rates, they have been progressively de-
creasing, particularly in younger women, due to 
the improved treatment and primary detection 
(5). In Iran with increasing life expectancy and 
the aging of the residents, the incidence and mor-
tality of BC will increase in the future years (6).  
In GLOBOCAN project, the expected number 
of new cancer cases or deaths in a country or re-
gion in 2015-2035 is computed by multiplying the 
age-specific incidence/mortality rates estimated 
for 2012, by the corresponding expected popula-
tion for 2015-2035. In Iran, based on the GLO-
BOCAN project in 2012, the number of BC in 
woman was 9795 case and the number of new 
case have an increase in the next few years, so in 
2015, 2020, 2025, 2030 and 2035 the number of 
new cases were 10982, 12684, 14920, 17346 and 
19328, respectively. Therefore, in 2035 compare 
2012 the numbers of new case were nearly 2 
times. In addition, in 2012, the numbers of death 
from BC was 3304 and in the next few years, we 
have increase in the number of death from BC, 
so in 2015, 2020, 2025, 2030 and 2035 the num-
bers of deaths were 3742, 4394, 5248, 6220 and 
7138. We expect that Iranian population struc-
ture, the greatest increase in the number of new 
cases and deaths from BC observe in age group 
(ages >= 65), so in 2035 compared to 2012, the 
number of new case and mortality will be 3 times, 
while in the age group below 65 yr, the increase is 
about 1.8 times (7) (Table 1, Fig. 1). 
We predicted the number of incidence and mor-
tality of BC in Iran between 2012 and 2035. Al-
though these results should be taken with cau-
tion given that they were obtained using predic-
tion methods, it is important to highlight that 
there is a trend for increased incidence and mor-
tality of BC in Iran. For this reason, in addition 
to planning for prevention of disease occurrence 
in the population at risk, the health policy makers 
should anticipate and provide diagnostic tools, 
therapeutic facilities, and skilled healthcare work-
ers to cope with these additional patients in the 
next few years. 
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Table 1: Predict the number of incidence and mortality from breast cancers in Iran 
 
Year Estimated number of new cancers Estimated number of cancer deaths 
Ages < 65 Ages >= 65 All Ages < 65 Ages >= 65 All 
2012 8390 1405 9795 2465 839 3304 
2015 9342 1640 10982 2772 970 3742 
2020 10556 2128 12684 3154 1240 4394 
2025 12203 2717 14920 3661 1587 5248 
2030 13886 3460 17346 4184 2036 6220 
2035 14985 4343 19328 4565 2573 7138 
Population forecasts were extracted from the United Nations, World Population prospects, the 2012 revision. 
Numbers are computed using age-specific rates and corresponding populations for 10 age groups. GLOBOCAN 
2012 (IARC) - 15.3.2016 
 
 
 
Fig. 1: Predict the number of incidence and mortality of breast cancers in Iran 
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